OpenURL Connection Search

Select item for more details and to access through your institution.

Defining and Treating Older Adults with Acute Myeloid Leukemia who Are ineligible for intensive Therapies.
Published in:
Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00280
By:
- Pettit, Kristen;
- Odenike, Olatoyosi;
- Majlis, Alejandro;
- Buccisano, Francesco
Publication type:
Article
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.
Published in:
Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-017-0550-8
By:
- Wang, Amy Y.;
- Weiner, Howard;
- Green, Margaret;
- Chang, Hua;
- Fulton, Noreen;
- Larson, Richard A.;
- Odenike, Olatoyosi;
- Artz, Andrew S.;
- Bishop, Michael R.;
- Godley, Lucy A.;
- Thirman, Michael J.;
- Kosuri, Satyajit;
- Churpek, Jane E.;
- Curran, Emily;
- Pettit, Kristen;
- Stock, Wendy;
- Liu, Hongtao
Publication type:
Article
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML.
Published in:
In Vivo, 2022, v. 36, n. 4, p. 1615, doi. 10.21873/invivo.12872
By:
- ALBERT, DANIEL H.;
- GOODWIN, NEAL C.;
- DAVIES, ANGELA M.;
- ROWE, JENNY;
- FEUER, GEROLD;
- BOYIADZIS, MICHAEL;
- DORRITIE, KATHLEEN A.;
- MANCINI, MARIA;
- GANDOUR-EDWARDS, REGINA;
- JONAS, BRIAN A.;
- BORTHAKUR, GAUTAM;
- ALDOSS, IBRAHIM;
- RIZZIERI, DAVID A.;
- ODENIKE, OLATOYOSI;
- PREBET, THOMAS;
- SINGH, SANJANA;
- POPOVIC, RELJA;
- SHEN, YU;
- MCDANIEL, KEITH F.;
- KATI, WARREN M.
Publication type:
Article
Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib.
Published in:
British Journal of Haematology, 2020, v. 190, n. 1, p. e48, doi. 10.1111/bjh.16709
By:
- Patel, Anand A.;
- Cahill, Kirk;
- Charnot‐Katsikas, Angella;
- Liu, Hongtao;
- Gurbuxani, Sandeep;
- Thirman, Michael;
- Kosuri, Satyajit;
- Artz, Andrew S.;
- Larson, Richard A.;
- Stock, Wendy;
- Segal, Jeremy;
- Odenike, Olatoyosi
Publication type:
Article
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
Published in:
Investigational New Drugs, 2015, v. 33, n. 2, p. 371, doi. 10.1007/s10637-014-0194-2
By:
- Odenike, Olatoyosi;
- Halpern, Anna;
- Godley, Lucy;
- Madzo, Jozef;
- Karrison, Theodore;
- Green, Margaret;
- Fulton, Noreen;
- Mattison, Ryan;
- Yee, Karen.;
- Bennett, Meghan;
- Koval, Gregory;
- Malnassy, Gregory;
- Larson, Richard;
- Ratain, Mark;
- Stock, Wendy
Publication type:
Article
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2023, v. 98, n. 2, p. 272, doi. 10.1002/ajh.26771
By:
- Zeidan, Amer M.;
- Borate, Uma;
- Pollyea, Daniel A.;
- Brunner, Andrew M.;
- Roncolato, Fernando;
- Garcia, Jacqueline S.;
- Filshie, Robin;
- Odenike, Olatoyosi;
- Watson, Anne Marie;
- Krishnadasan, Ravitharan;
- Bajel, Ashish;
- Naqvi, Kiran;
- Zha, Jiuhong;
- Cheng, Wei‐Han;
- Zhou, Ying;
- Hoffman, David;
- Harb, Jason G.;
- Potluri, Jalaja;
- Garcia‐Manero, Guillermo
Publication type:
Article
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant.
Published in:
Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0125-6
By:
- Fan, Yun;
- Artz, Andrew S.;
- van Besien, Koen;
- Stock, Wendy;
- Larson, Richard A.;
- Odenike, Olatoyosi;
- Godley, Lucy A.;
- Kline, Justin;
- Cunningham, John M.;
- LaBelle, James L.;
- Bishop, Michael R.;
- Liu, Hongtao
Publication type:
Article
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
Published in:
Experimental Hematology & Oncology, 2018, v. 7, p. 1, doi. 10.1186/s40164-018-0093-x
By:
- Liu, Hongtao;
- Zha, Yuanyuan;
- Choudhury, Noura;
- Malnassy, Gregory;
- Fulton, Noreen;
- Green, Margaret;
- Park, Jae-Hyun;
- Nakamura, Yusuke;
- Larson, Richard A.;
- Salazar, Andres M.;
- Odenike, Olatoyosi;
- Gajewski, Thomas F.;
- Stock, Wendy
Publication type:
Article
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
Published in:
Annals of Hematology, 2024, v. 103, n. 1, p. 105, doi. 10.1007/s00277-023-05552-4
By:
- Bewersdorf, Jan Philipp;
- Shallis, Rory M.;
- Sharon, Elad;
- Park, Silvia;
- Ramaswamy, Rahul;
- Roe, Caroline E.;
- Irish, Jonathan M.;
- Caldwell, Anne;
- Wei, Wei;
- Yacoub, Abdulraheem;
- Madanat, Yazan F.;
- Zeidner, Joshua F.;
- Altman, Jessica K.;
- Odenike, Olatoyosi;
- Yerrabothala, Swaroopa;
- Kovacsovics, Tibor;
- Podoltsev, Nikolai A.;
- Halene, Stephanie;
- Little, Richard F.;
- Piekarz, Richard
Publication type:
Article
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)
Published in:
2013
By:
- Gupta, Pankaj;
- Mulkey, Flora;
- Hasserjian, Robert;
- Sanford, Ben;
- Vij, Ravi;
- Hurd, David;
- Odenike, Olatoyosi;
- Bloomfield, Clara;
- Owzar, Kouros;
- Stone, Richard;
- Larson, Richard
Publication type:
Journal Article
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).
Published in:
Investigational New Drugs, 2013, v. 31, n. 5, p. 1311, doi. 10.1007/s10637-013-9978-z
By:
- Gupta, Pankaj;
- Mulkey, Flora;
- Hasserjian, Robert;
- Sanford, Ben;
- Vij, Ravi;
- Hurd, David;
- Odenike, Olatoyosi;
- Bloomfield, Clara;
- Owzar, Kouros;
- Stone, Richard;
- Larson, Richard
Publication type:
Article
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
Published in:
Investigational New Drugs, 2008, v. 26, n. 4, p. 331, doi. 10.1007/s10637-008-9129-0
By:
- Wendy Stock;
- Samir Undevia;
- Carol Bivins;
- Farhad Ravandi;
- Olatoyosi Odenike;
- Stefan Faderl;
- Elizabeth Rich;
- Gautam Borthakur;
- Lucy Godley;
- Srdan Verstovsek;
- Andrew Artz;
- William Wierda;
- Richard Larson;
- Yanming Zhang;
- Jorge Cortes;
- Mark Ratain;
- Francis Giles
Publication type:
Article
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
Published in:
Investigational New Drugs, 2008, v. 26, n. 3, p. 233, doi. 10.1007/s10637-008-9115-6
By:
- Odenike, Olatoyosi M.;
- Larson, Richard A.;
- Gajria, Devika;
- Dolan, M. Eileen;
- Delaney, Shannon M.;
- Karrison, Theodore G.;
- Ratain, Mark J.;
- Stock, Wendy
Publication type:
Article
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Published in:
Advanced Science, 2023, v. 10, n. 23, p. 1, doi. 10.1002/advs.202300445
By:
- Liang, Guanghao;
- Wang, Linchen;
- You, Qiancheng;
- Cahill, Kirk;
- Chen, Chuanyuan;
- Zhang, Wei;
- Fulton, Noreen;
- Stock, Wendy;
- Odenike, Olatoyosi;
- He, Chuan;
- Han, Dali
Publication type:
Article
SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 303, doi. 10.1016/j.clml.2023.01.011
By:
- Patel, Anand A.;
- Odenike, Olatoyosi
Publication type:
Article
MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S343, doi. 10.1016/S2152-2650(21)01798-5
By:
- Wei, Andrew H.;
- Garcia, Jacqueline S.;
- Borate, Uma;
- Chun Yew Fong;
- Baer, Maria R.;
- Nowak, Daniel;
- Peterlin, Pierre;
- Jurcic, Joseph;
- Jacoby, Meagan A.;
- Platzbecker, Uwe;
- Odenike, Olatoyosi;
- Cunningham, Ilona;
- Ying Zhou;
- Hoffman, David;
- Hogdal, Leah;
- Naqvi, Kiran;
- Kye, Steve;
- Garcia-Manero, Guillermo
Publication type:
Article
Poster: MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01429-4
By:
- Wei, Andrew H.;
- Garcia, Jacqueline S.;
- Borate, Uma;
- Chun Yew Fong;
- Baer, Maria R.;
- Nowak, Daniel;
- Peterlin, Pierre;
- Jurcic, Joseph;
- Jacoby, Meagan A.;
- Platzbecker, Uwe;
- Odenike, Olatoyosi;
- Cunningham, Ilona;
- Ying Zhou;
- Hoffman, David;
- Hogdal, Leah;
- Naqvi, Kiran;
- Kye, Steve;
- Garcia-Manero, Guillermo
Publication type:
Article
Accelerated Phase of MPN: What Is It and What to Do About It.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S127, doi. 10.1016/S2152-2650(21)01237-4
By:
- Odenike, Olatoyosi
Publication type:
Article
OTS167 Inhibits FLT3 Expression in FLT3 Mutant Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S239, doi. 10.1016/j.clml.2019.07.133
By:
- Eisfelder, Bartholomew;
- Wynne, Joseph;
- Colton, Margert;
- Cheng, Jason;
- Odenike, Olatoyosi;
- Alachkar, Houda;
- Stock, Wendy
Publication type:
Article
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.
Published in:
2019
By:
- Ragon, Brittany Knick;
- Odenike, Olatoyosi;
- Baer, Maria R.;
- Stock, Wendy;
- Borthakur, Gautam;
- Patel, Keyur;
- Han, Lina;
- Chen, Helen;
- Ma, Helen;
- Joseph, Loren;
- Zhao, Yang;
- Baggerly, Keith;
- Konopleva, Marina;
- Jain, Nitin
Publication type:
journal article
First-In-Human Study of ABBV-075 (Mivebresib), A Pan-Inhibitor of Bromodomain and Extra Terminal (BET) Proteins, in Patients (Pts) With Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML): Preliminary Data.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S203, doi. 10.1016/j.clml.2018.07.054
By:
- Borthakur, Gautam;
- Wolff, Johannes;
- Aldoss, Ibrahim;
- Hu, Beibei;
- Dinh, Minh;
- Torres, Alison;
- Chen, Xiaotian;
- Rizzieri, David;
- Sood, Anjla;
- Odenike, Olatoyosi;
- Jonas, Brian A.
Publication type:
Article
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
Published in:
Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 553, doi. 10.1007/s00280-004-0857-3
By:
- Odenike, Olatoyosi M.;
- Sobecks, Ronald M.;
- Janisch, Linda;
- Huo, Dezheng;
- Zimmerman, Todd M.;
- Daugherty, Christopher K.;
- Ratain, Mark J.;
- Larson, Richard A.
Publication type:
Article
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00433-3
By:
- Eisfelder, Bartholomew J.;
- Saygin, Caner;
- Wynne, Joseph;
- Colton, Margaret W.;
- Fischietti, Mariafausta;
- Beauchamp, Elspeth M.;
- Cheng, Jason X.;
- Odenike, Olatoyosi;
- Roboz, Gail;
- Alachkar, Houda;
- Stock, Wendy
Publication type:
Article
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.
Published in:
Current Hematologic Malignancy Reports, 2020, v. 15, n. 6, p. 409, doi. 10.1007/s11899-020-00596-z
By:
- Patel, Anand A.;
- Odenike, Olatoyosi
Publication type:
Article
Novel Therapies for Myelofibrosis.
Published in:
Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 611, doi. 10.1007/s11899-017-0403-0
By:
- Pettit, Kristen;
- Odenike, Olatoyosi
Publication type:
Article
A multi‐institutional comparison of mitoxantrone, etoposide, and cytarabine vs high‐dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.
Published in:
American Journal of Hematology, 2020, v. 95, n. 8, p. 937, doi. 10.1002/ajh.25838
By:
- Christian, Sonia;
- Arain, Saad;
- Patel, Pritesh;
- Khan, Irum;
- Calip, Gregory S.;
- Agrawal, Vaibhav;
- Sweiss, Karen;
- Griffin, Shawn;
- Cahill, Kirk;
- Konig, Heiko;
- Esen, Aysenur;
- Shergill, Ardaman;
- Odenike, Olatoyosi;
- Stock, Wendy;
- Quigley, John G.
Publication type:
Article
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium.
Published in:
American Journal of Hematology, 2012, v. 87, n. 5, p. 562, doi. 10.1002/ajh.23169
By:
- Abdel-Wahab, Omar;
- Pardanani, Animesh;
- Bernard, Olivier A.;
- Finazzi, Guido;
- Crispino, John D.;
- Gisslinger, Heinz;
- Kralovics, Robert;
- Odenike, Olatoyosi;
- Bhalla, Kapil;
- Gupta, Vikas;
- Barosi, Giovanni;
- Gotlib, Jason;
- Guglielmelli, Paola;
- Kiladjian, Jean-Jacques;
- Noel, Pierre;
- Cazzola, Mario;
- Vannucchi, Alessandro M.;
- Hoffman, Ronald;
- Barbui, Tiziano;
- Thiele, Juergen
Publication type:
Article
Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies.
Published in:
Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0367-x
By:
- Verstovsek, Srdan;
- Odenike, Olatoyosi;
- Singer, Jack W.;
- Granston, Tanya;
- Al-Fayoumi, Suliman;
- Deeg, H. Joachim
Publication type:
Article
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts.
Published in:
Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-81
By:
- Talpaz, Moshe;
- Paquette, Ronald;
- Afrin, Lawrence;
- Hamburg, Solomon I.;
- Prchal, Josef T.;
- Jamieson, Katarzyna;
- Terebelo, Howard R.;
- Ortega, Gregory L.;
- Lyons, Roger M.;
- Tiu, Ramon V.;
- Winton, Elliott F.;
- Natrajan, Kavita;
- Odenike, Olatoyosi;
- Claxton, David;
- Peng, Wei;
- O'Neill, Peter;
- Erickson-Viitanen, Susan;
- Leopold, Lance;
- Sandor, Victor;
- Levy, Richard S.
Publication type:
Article
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions.
Published in:
2018
By:
- Steensma, David P.;
- Brunner, Andrew M.;
- DeZern, Amy E.;
- Garcia‐Manero, Guillermo;
- Komrokji, Rami S.;
- Odenike, Olatoyosi S.;
- Roboz, Gail J.;
- Savona, Michael R.;
- Stone, Richard M.;
- Sekeres, Mikkael A.;
- Garcia-Manero, Guillermo
Publication type:
journal article
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Published in:
Cancer (0008543X), 2021, v. 127, n. 16, p. 2943, doi. 10.1002/cncr.33590
By:
- Borthakur, Gautam;
- Odenike, Olatoyosi;
- Aldoss, Ibrahim;
- Rizzieri, David A.;
- Prebet, Thomas;
- Chen, Chris;
- Popovic, Relja;
- Modi, Dimple A.;
- Joshi, Rujuta H.;
- Wolff, Johannes E.;
- Jonas, Brian A.
Publication type:
Article
Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults.
Published in:
EJHaem, 2021, v. 2, n. 3, p. 413, doi. 10.1002/jha2.224
By:
- Patel, Anand Ashwin;
- Heng, Joseph;
- Dworkin, Emily;
- Monick, Sarah;
- Derman, Benjamin A.;
- DuVall, Adam S.;
- Gurbuxani, Sandeep;
- Kosuri, Satyajit;
- Liu, Hongtao;
- Thirman, Michael;
- Godley, Lucy A.;
- Odenike, Olatoyosi;
- Larson, Richard A.;
- Stock, Wendy
Publication type:
Article
Leukaemogenesis: more than mutant genes.
Published in:
2010
By:
- Jianjun Chen;
- Odenike, Olatoyosi;
- Rowley, Janet D.;
- Chen, Jianjun
Publication type:
journal article
Secondary Acute Myeloid Leukemias Arising From Philadelphia Chromosome Negative Myeloproliferative Neoplasms: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Published in:
Current Hematologic Malignancy Reports, 2015, v. 10, n. 2, p. 112, doi. 10.1007/s11899-015-0259-0
By:
- Tallarico, Michael;
- Odenike, Olatoyosi
Publication type:
Article

Found: 34